ATE213416T1 - Arzneizubereitungen enthaltend cefuroxim axetil - Google Patents

Arzneizubereitungen enthaltend cefuroxim axetil

Info

Publication number
ATE213416T1
ATE213416T1 AT98940001T AT98940001T ATE213416T1 AT E213416 T1 ATE213416 T1 AT E213416T1 AT 98940001 T AT98940001 T AT 98940001T AT 98940001 T AT98940001 T AT 98940001T AT E213416 T1 ATE213416 T1 AT E213416T1
Authority
AT
Austria
Prior art keywords
preparations containing
medicinal preparations
axetil
cefuroxim
precipitate
Prior art date
Application number
AT98940001T
Other languages
English (en)
Inventor
Bernard Charles Sherman
Original Assignee
Bernard Charles Sherman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4161029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE213416(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman
Application granted granted Critical
Publication of ATE213416T1 publication Critical patent/ATE213416T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
AT98940001T 1997-08-15 1998-08-07 Arzneizubereitungen enthaltend cefuroxim axetil ATE213416T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002209868A CA2209868C (en) 1997-08-15 1997-08-15 Pharmaceutical compositions comprising cefuroxime axetil
PCT/CA1998/000773 WO1999008683A1 (en) 1997-08-15 1998-08-07 Pharmaceutical compositions comprising cefuroxime axetil

Publications (1)

Publication Number Publication Date
ATE213416T1 true ATE213416T1 (de) 2002-03-15

Family

ID=4161029

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98940001T ATE213416T1 (de) 1997-08-15 1998-08-07 Arzneizubereitungen enthaltend cefuroxim axetil

Country Status (7)

Country Link
EP (1) EP0996449B1 (de)
AT (1) ATE213416T1 (de)
AU (1) AU8847098A (de)
CA (1) CA2209868C (de)
DE (1) DE69803930T2 (de)
ES (1) ES2172182T3 (de)
WO (1) WO1999008683A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0937727B1 (de) * 1998-02-20 2002-01-30 Fako Ilaclari A.S. Verfahren zur Herstellung vom löslichen kristallinen Cefuroxim axetil
CA2239331C (en) * 1998-05-29 1999-11-30 Bernard Charles Sherman Pharmaceutical tablets comprising cefuroxime axetil
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
CA2280925A1 (en) 1999-07-29 2001-01-29 Bernard Charles Sherman Stabilized cefuroxime axetil
CZ12993U1 (cs) * 2001-11-23 2003-02-10 Glaxo Group Limited Farmaceutický prostředek
WO2005002540A2 (en) * 2003-07-01 2005-01-13 Ranbaxy Laboratories Limited Dry powder pharmaceutical suspension compositions of cefuroxime axetil
JP2007517864A (ja) * 2004-01-09 2007-07-05 ハンミ ファーム． シーオー．， エルティーディー． セフロキシムアキセチル顆粒及びこの製造方法
CN100402035C (zh) * 2005-07-07 2008-07-16 石药集团中奇制药技术（石家庄）有限公司 一种微囊化头孢呋辛酯的药物组合物
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
CN101890023B (zh) * 2010-08-16 2013-03-27 海南日中天制药有限公司 头孢呋辛酯口服剂及其制备方法
CN115887468B (zh) * 2022-11-17 2025-02-07 华北制药河北华民药业有限责任公司 一种空心球形头孢呋辛酯制剂原粉及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
CA1316110C (en) * 1987-02-27 1993-04-13 Eli Lilly And Company Sustained release matrix formulations
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
IT1277426B1 (it) * 1995-08-03 1997-11-10 Acs Dobfar Spa Forma cristallina biodisponibile del cefuroxima axetil
DE19631085A1 (de) * 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Maleinsäure-Copolymeren zur Verbesserung der Permeabilität der Schleimhaut
IL119627A (en) * 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT

Also Published As

Publication number Publication date
DE69803930T2 (de) 2002-10-17
ES2172182T3 (es) 2002-09-16
EP0996449A1 (de) 2000-05-03
EP0996449B1 (de) 2002-02-20
DE69803930D1 (de) 2002-03-28
CA2209868C (en) 2001-08-14
WO1999008683A1 (en) 1999-02-25
CA2209868A1 (en) 1999-02-15
AU8847098A (en) 1999-03-08

Similar Documents

Publication Publication Date Title
HUP9900391A2 (hu) Rapamicineket tartalmazó gyógyszerkészítmények
GEP20053420B (en) Sustained Release Ranolanolazine Formulation
AU7052798A (en) Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates
AU7052698A (en) Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates
FI973278A7 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
MXPA02003596A (es) Composiciones farmaceuticas novedosas de farmacos anti tubercular y procedimiento para su preparacion.
GEP20032995B (en) 1-Amino-Alkylcyclohexane NMDA Receptor Antagonists
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
MY123193A (en) Novel 2-(iminomethyl)amino-phenyl derivatives,preparation,application as medicines and compositions containing same
EE200100073A (et) Pulberinhalaatori kaheosaline kapsel farmatseutiliste preparaatide mahutamiseks
IL147220A0 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
FI964920A7 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
HUP9800688A2 (hu) Gamma-ciklodextrin és retinol, ill. retinolszármazékok komplexei, eljárás ezek előállítására és ezeket tartalmazó kozmetikai és gyógyszerkészítmények
MY124146A (en) Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
AU5157590A (en) Pharmaceutical compositions for oral administration
ATE213416T1 (de) Arzneizubereitungen enthaltend cefuroxim axetil
FI951357L (fi) Farmaseuttiset koostumukset, jotka mahdollistavat trimetatsidiinin hidastetun vapautumisen oraalisen annostuksen jälkeen
FI955310L (fi) Farmaseuttinen koostumus flavonoidien antamiseksi oraalisesti
FI954986L (fi) Uudet, suun kautta annettavat, syklosporiinia sisältävät farmaseuttiset valmisteet
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
AU1463992A (en) Methods and pharmaceutical compositions for inhibiting protease from human immunodeficiency virus
PT1131297E (pt) Certas caprolactamas substituidas composicoes farmaceuticas contendo-as e sua utilizacao no tratamento de tumores
HUP0400889A2 (hu) Eljárások (R)-alfa-(2,3-dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol előállítására és a vegyületet tartalmazó gyógyszerkészítmények
BG106151A (en) Pharmaceutical complex

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties